| Literature DB >> 24024120 |
G Dharmadhikari1, M Mühle, F T Schulthess, S Laue, J Oberholzer, F Pattou, J Kerr-Conte, K Maedler.
Abstract
Decreased β-cell mass reflects a shift from quiescence/proliferation into apoptosis, it plays a crucial role in the pathophysiology of diabetes. A major attempt to restore β-cell mass and normoglycemia is to improve β-cell survival. Here we show that switching off the Fas pathway using Fas apoptotic inhibitory protein (Faim/TOSO), which regulates apoptosis upstream of caspase 8, blocked β-cell apoptosis and increased proliferation in human islets. TOSO was clearly expressed in pancreatic β-cells and down-regulated in T2DM. TOSO expression correlated with β-cell turnover; at conditions of improved survival, TOSO was induced. In contrast, TOSO downregulation induced β-cell apoptosis. Although TOSO overexpression resulted in a 3-fold induction of proliferation, proliferating β-cells showed a very limited capacity to undergo multiple rounds of replication. Our data suggest that TOSO is an important regulator of β-cell turnover and switches β-cell apoptosis into proliferation.Entities:
Keywords: Diabetes; Fas; Islets; TOSO; β-cell proliferation
Year: 2012 PMID: 24024120 PMCID: PMC3757648 DOI: 10.1016/j.molmet.2012.08.006
Source DB: PubMed Journal: Mol Metab ISSN: 2212-8778 Impact factor: 7.422